Moreover, studies delivered proof of the concept that EGFR-CAR-NK cells could be applied for treating patients suffering from triple-negative breast cancer (TNBC) displaying heightened EGFR expression. The gene discussed is EGFR; the disease is triple-negative breast carcinoma.